Navigation Links
Dual method to remove precancerous colon polyps may substantially reduce health-care costs
Date:5/5/2014

Chicago, IL (May 5, 2014) A surgical method combining two techniques for removing precancerous polyps during colonoscopies can substantially reduce the recovery time and the length of hospital stays, potentially saving the health-care system millions of dollars, according to research presented today at Digestive Disease Week (DDW).

"Not only did we find that patients were discharged a day and a half earlier, we discovered other benefits, which could transform our approach to removing difficult colon polyps," said Jonathan Buscaglia, MD, the study's lead researcher and the director of advanced endoscopy at Stony Brook University School of Medicine.

The typical approach to these difficult-to-remove polyps is a procedure called laparoscopic hemicolectomy (LHC), in which surgeons using a laparoscope must remove an entire section of the colon that contains the polyp. But in contrast to this invasive procedure, surgeons employing laparoscopic-assisted colonoscopy with polypectomy (LACP) use both a laparoscope and an endoscope to isolate and remove just the polyp.

In addition to shorter discharge time (four days vs. two and a half days), researchers found that operating time for patients undergoing LACP was significantly shorter than patients undergoing LHC (95 minutes vs. 179 minutes). LACP patients also had far less estimated blood loss (13 ml vs. 63 ml) and required less IV fluid (2.1 liters vs. 3.1 liters). After surgery, LACP patients were able to resume eating solids foods in less than two days, while LHC patients had to wait nearly four days. Researchers found the two procedures were equivalent in terms of overall efficacy and complications.

Because this study involved 28 patients, Dr. Buscaglia and his team plan to conduct a larger, multi-center investigation to confirm these findings. The researchers also hope to compare LACP versus LHC on removal of polyps in the left colon since this study looked exclusively at right-side colonic polyp removal.

"About 25 percent of patients undergoing colonoscopy require polyp removal, and a significant proportion of these patients have large polyps that cannot be easily removed by standard advanced endoscopic techniques," said Dr. Buscaglia. "These findings suggest that we may need to tailor our surgical approach to ensure every patient receives the best care possible, regardless of polyp removal difficulty."

Dr. Jonathan Buscaglia will present data from the study "Laparoscopic-assisted colonoscopy with polypectomy versus laparoscopic hemicolectomy for endoscopically unresectable right-sided colon polyps: results of a randomized controlled trial," abstract 611, on May 5, at 8 a.m. CT, in room S404 of McCormick Place. For more information about featured studies, as well as a schedule of availability for featured researchers, please visit http://www.ddw.org/press.


'/>"/>

Contact: Aimee Frank
newsroom@gastro.org
301-941-2620
Digestive Disease Week
Source:Eurekalert

Related medicine news :

1. Nonsurgical Method to Measure Brain Pressure Shows Promise
2. New Method to Reveal Alzheimers Marker Shows Promise
3. New method to measure work addiction
4. Advanced genetic screening method may speed vaccine development
5. OHSU Oregon National Primate Research Center develops new, safer method for making vaccines
6. Hear to see: New method for the treatment of visual field defects
7. Safer Grilling Methods Might Cut Cancer Risk
8. Quick-Reversal Method May Be at Hand for New Blood Thinner
9. New delivery method improves efficacy of 2 common Parkinsons disease medications
10. Electronic data methods research seeks to build a learning health care system
11. New Stanford method enables sequencing of fetal genomes using only maternal blood sample
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... 26, 2017 , ... New SUPRO® XT55 Isolated Soy ... by helping beverage manufacturers more effectively manage protein costs. “Soy protein has always ... well as more stable pricing over time. Now it’s even more relevant as ...
(Date:4/25/2017)... ... April 25, 2017 , ... Bellus ... that’s the first in a new class of photodynamic cosmetics (PDC). , Allumera® ... skin, visibly reduce outward signs of aging, and minimize the appearance of pores ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne research, ... cells) Phase I/II HOPE clinical trial in Duchenne announced today. , Coalition ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent ... test score performance for the 2015-16 school year across Wisconsin’s public schools, charter ... it highlights important patterns in student test score performance, the report’s limited analyses ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who ... achieves results in a fraction of the time as traditional braces – Wilckodontics®. ... Dental Specialists, now offers this revolutionary treatment with or without a referral. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  Vivify Health, the pioneer and market leader ... a very significant patent for the advancement of healthcare ... via digital health.  This landmark patent provides the company ... secures Vivify,s position as the leader in remote care.  ... first company to apply consumer mobile devices, wireless biometrics, ...
(Date:4/20/2017)... April 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Company,s consumer product development program, based on its ... for Investigative Dermatology (SID) 76 th Annual ... promote the sciences relevant to skin health and ...
(Date:4/20/2017)... BOSTON , April 20, 2017   ZappRx, Inc ... the specialty drug prescribing process, today announced it closed $25 ... Fund, a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included ... A round in 2014, and GV (formerly Google ...
Breaking Medicine Technology: